Cargando…

Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors

This study was performed to evaluate the effects of 15-month anti-tumor necrosis factor α (anti-TNF-α) therapy on the aggrecan turnover of female rheumatoid arthritis (RA) patients. Serum was obtained from healthy subjects and female RA patients treated with TNF-α inhibitors (TNFαI) in combination w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeremeta, Anna, Jura-Półtorak, Agnieszka, Zoń-Giebel, Aleksandra, Kopeć-Mędrek, Magdalena, Kucharz, Eugeniusz Józef, Olczyk, Krystyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290997/ https://www.ncbi.nlm.nih.gov/pubmed/32392807 http://dx.doi.org/10.3390/jcm9051377

Ejemplares similares

Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
por: Szeremeta, Anna, et al.
Publicado: (2018)

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors
por: Jura-Półtorak, Agnieszka, et al.
Publicado: (2021)

TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis
por: Szeremeta, Anna, et al.
Publicado: (2022)

Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis
por: Szeremeta, Anna, et al.
Publicado: (2023)

Laboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis
por: Winsz-Szczotka, Katarzyna, et al.
Publicado: (2016)

Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist
por: Kopec-Medrek, Magdalena, et al.
Publicado: (2011)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2020)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases
por: Kotulska, Anna, et al.
Publicado: (2015)

Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management
por: Kucharz, Eugeniusz J., et al.
Publicado: (2019)

Circulating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin Therapy
por: Komosinska-Vassev, Katarzyna, et al.
Publicado: (2019)

Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases
por: Komosinska-Vassev, Katarzyna, et al.
Publicado: (2022)

Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease
por: Kałużna, Aleksandra, et al.
Publicado: (2023)

The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity
por: Komosinska-Vassev, Katarzyna, et al.
Publicado: (2020)

The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative Colitis
por: Derkacz, Alicja, et al.
Publicado: (2021)

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab
por: Magiera, Michal, et al.
Publicado: (2011)

Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis
por: Kałużna, Aleksandra, et al.
Publicado: (2023)

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile
por: Rousseau, Jean C, et al.
Publicado: (2008)

Opinion of patients with ankylosing spondylitis on risk factors impairing their quality of life
por: Kucharz, Eugene J., et al.
Publicado: (2012)

Proteoglycan Aggrecan Conducting T Cell Activation and Apoptosis in a Murine Model of Rheumatoid Arthritis
por: Hanyecz, A., et al.
Publicado: (2014)

Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis
por: Markovics, Adrienn, et al.
Publicado: (2016)

Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2022)

Osseous manifestations of sarcoidosis
por: Kucharz, Eugeniusz Józef
Publicado: (2020)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir
por: Olczyk, Paweł, et al.
Publicado: (2017)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Concerted Actions by PIICP, CTXII, and TNF-α in Patients with Juvenile Idiopathic Arthritis
por: Winsz-Szczotka, Katarzyna, et al.
Publicado: (2021)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Histidine deficiency does not protect against aggrecan-induced arthritis
por: Nagy, Gyorgy, et al.
Publicado: (2007)

GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept—Relationship with ADAMTS4, ADAMTS5, and PDGF-BB
por: Dąbkowska, Klaudia, et al.
Publicado: (2022)

The role of aggrecan in normal and osteoarthritic cartilage
por: Roughley, Peter J, et al.
Publicado: (2014)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

Effect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblasts in vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018)

In memoriam Professor Ugo Efisio Francesco Carcassi
por: Kucharz, Eugeniusz J.
Publicado: (2016)

The 33(rd) World Congress of Internal Medicine: Nusa Dua, Indonesia, August 22–25, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2016)

Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate
por: Kucharz, Eugeniusz J.
Publicado: (2017)

The 11(th) Central European Congress of Rheumatology: Prague, December 8–10, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2017)

Medical eponyms from linguistic and historical points of view
por: Kucharz, Eugeniusz Józï
Publicado: (2020)

Hit two birds with one stone: why crystalline glucosamine sulphate used for osteoarthritis medication is beneficial for patients with risk of cardiovascular disorders
por: Kucharz, Eugeniusz J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q89vjegscue5sr16j9aitm0ehd